Microfluidic Chip for Blood-Brain Barrier and Spinal Cord Modeling

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current in vitro systems for culturing brain cells, particularly astrocytes and endothelial cells, fail to accurately mimic the structure and function of the blood-brain barrier and spinal cord, limiting the ability to measure barrier integrity and physiology effectively.

Innovation Solution

Culturing endothelial cells, optionally with astrocytes, neurons, and pericytes, in a microfluidic device under conditions that mimic the structural and functional features of the blood-brain barrier and spinal cord, such as tight junctions, using iPSC-derived cells and flow conditions to enhance maturation and differentiation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If cells are cultured in traditional static in vitro systems, then the culture setup is simple and easy to maintain, but the cells fail to accurately mimic the structure and function of the blood-brain barrier and spinal cord

Engineering Contradiction:
Improveaccuracy of BBB and spinal cord mimicryVSAvoidculture system complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent introduces dynamic fluid flow through microfluidic channels to replace static culture conditions. The flow conditions dynamically regulate cell behavior, promoting the formation of tight junctions and realistic BBB/spinal cord structures that accurately mimic in vivo environments while maintaining controllable complexity through standardized chip designs.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The patent transitions from traditional 2D static culture surfaces to 3D microfluidic environments with multiple compartments and flow dimensions. This dimensional enhancement allows cells to self-organize into more realistic tissue architectures with proper spatial relationships, improving BBB and spinal cord mimicry without proportionally increasing operational complexity.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Manufacturing precision

If neurons are cultured in static conditions, then the culture method is straightforward, but the neurons show less mature electrophysiology and slower maturation

Engineering Contradiction:
Improveneuronal maturation levelVSAvoidmaturation time
Core Design Contradiction:
Manufacturing precisionVSLoss of time

Solution Approach 1:

The microfluidic system applies dynamic flow conditions that mechanically stimulate neuronal cells, accelerating their maturation process. The controlled fluid shear stress and nutrient delivery promote faster development of mature electrophysiological properties, reducing the time required to achieve functional maturity compared to static cultures.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The patent modifies culture parameters by introducing controlled flow rates, oxygen gradients, and nutrient concentration variations through the microfluidic channels. These parameter changes create optimal conditions for rapid neuronal maturation, enhancing electrophysiological development while maintaining experimental control and reproducibility.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If complex co-culture systems are used to improve BBB mimicry, then the physiological relevance increases, but the system becomes more difficult to control and measure

Engineering Contradiction:
Improvephysiological relevance of BBB modelVSAvoidsystem control and measurement ease
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The patent divides the complex co-culture system into distinct microfluidic compartments separated by porous membranes or channels. Each compartment can house different cell types (endothelial cells, astrocytes, neurons) with independent media flow control. This segmentation allows physiological interactions to occur while maintaining separate control over each cell population, simplifying both operation and measurement of specific parameters.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The microfluidic chip structure itself acts as an intermediary that facilitates controlled interactions between different cell types. The chip's physical architecture, including porous membranes and channel geometries, mediates cell-cell and cell-media interactions, enabling complex co-culture physiology while maintaining experimental control through the standardized chip interface for measurements like TEER.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The microfluidic culture system promotes the maturation and differentiation of neural and endothelial cells, enabling more accurate measurements of barrier integrity and physiology through increased transepithelial electrical resistance, improved electrophysiology, and enhanced gene expression profiles.

Implementation Method 1

contact with flowing media

Methodology Applied
Scientific EffectFluid flow: Convection

Implementation Method 2

two microchannels separated by a porous membrane

Methodology Applied
Scientific EffectPermeation: Permeation

Implementation Method 3

mimic one or more structural or functional features (e.g. tight junctions)

Methodology Applied
Scientific EffectTight junctions: Cohesion

Implementation Method 4

measurements of barrier integrity and physiology, whether by trans-epithelial electrical resistance (TEER)

Methodology Applied
Scientific EffectElectrical resistance: Electrical Resistance

Data Source

PatentUS12209253B2Development of spinal cord on a microfluidic chip
Publication Date: 2025.01.28 EMULATE INC
  • US12209253B2 patent drawing
  • US12209253B2 patent drawing
  • US12209253B2 patent drawing

AI summary

The invention relates to culturing brain endothelial cells, and optionally astrocytes and neurons in a fluidic device under conditions whereby the cells mimic the structure and function of the blood brain barrier. Culture of such cells in a microfluidic device, whether alone or in combination with other cells, drives maturation and/or differentiation further than existing systems.